Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Improved Immunology Outcomes Associated With Feihe Lactoferrin Fortified With HMO in Infant Formula: A Randomized, Controlled Trial

NCT06158659 is registered in ClinicalTrials.gov with Heilongjiang Feihe Dairy Co. Ltd. as lead sponsor.

NCT NCT06158659
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06158659 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Improved Immunology Outcomes Associated With Feihe Lactoferrin Fortified With HMO in Infant Formula: A Randomized, Controlled Trial
Lead sponsor
Heilongjiang Feihe Dairy Co. Ltd.
Phase
Not applicable
Overall status
Completed
Start date
November 14, 2023
Completion date
April 3, 2025
Enrollment
240 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

cold, flu